The shRNAs #1 and #2 against ZRF1 showed an increase in the percentage of cells in the G1 phase, whereas shRNA #3 showed a trend towards G2/M arrest ( Figure 5 d).
← all excerpts
Neuronal Differentiation-Related Epigenetic Regulator <i>ZRF1</i> Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In Vitro.
1
—
—